2-[(E)-3-trifluoromethoxy-benzenesulfonylimino]-imidazolidine-1-carbodithioic acid 3-thioxo-5,6-dihydro-imidazo[2,1-c][1,2,4]thiadiazol-7-yl ester

ID: ALA378951

PubChem CID: 24205513

Max Phase: Preclinical

Molecular Formula: C15H13F3N6O3S5

Molecular Weight: 542.64

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=S(=O)(NC1=NCCN1C(=S)SN1CCn2c1nsc2=S)c1cccc(OC(F)(F)F)c1

Standard InChI:  InChI=1S/C15H13F3N6O3S5/c16-15(17,18)27-9-2-1-3-10(8-9)32(25,26)21-11-19-4-5-22(11)14(29)31-24-7-6-23-12(24)20-30-13(23)28/h1-3,8H,4-7H2,(H,19,21)

Standard InChI Key:  UWEMRDAZSRCRSC-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 32 35  0  0  0  0  0  0  0  0999 V2000
    1.0949  -11.7241    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.8676  -12.0211    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    2.3870  -11.3800    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1403  -10.9028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9390  -10.6867    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9806   -9.8615    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2078   -9.5645    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6885  -10.2095    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.2122  -11.4216    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1328  -10.1640    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -0.5482   -9.4506    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3710   -9.4506    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1328   -8.7371    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8576   -8.7840    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430   -9.0391    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6430   -9.8620    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8576  -10.1171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6025  -10.9024    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1892  -11.4890    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6025  -12.0718    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7720  -10.9024    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.7720  -12.0718    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5647  -11.8570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.1472  -12.4390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9341  -13.2360    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.1332  -13.4478    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5542  -12.8644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9174  -14.2420    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1218  -14.4522    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3315  -14.6612    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9116  -13.6566    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3269  -15.2491    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  3  9  2  0
  8 10  1  0
 10 11  1  0
 11 12  1  0
 11 13  2  0
 12 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 12  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 19 21  2  0
 19 22  1  0
 22 23  2  0
  1  2  1  0
 23 24  1  0
  2  3  1  0
 24 25  2  0
  3  5  1  0
 25 26  1  0
  4  1  2  0
 26 27  2  0
 27 22  1  0
  4  5  1  0
 26 28  1  0
  5  6  1  0
 28 29  1  0
  6  7  1  0
 29 30  1  0
  7  8  1  0
 29 31  1  0
  8  4  1  0
 29 32  1  0
M  END

Associated Targets(Human)

KYSE-510 (286 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RPMI-8226 (44974 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 542.64Molecular Weight (Monoisotopic): 541.9605AlogP: 2.98#Rotatable Bonds: 4
Polar Surface Area: 92.06Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 9.51CX Basic pKa: 1.50CX LogP: 5.20CX LogD: 5.19
Aromatic Rings: 2Heavy Atoms: 32QED Weighted: 0.46Np Likeness Score: -1.72

References

1. Saczewski J, Brzozowski Z, Saczewski F, Bednarski PJ, Liebeke M, Gdaniec M..  (2006)  Synthesis and in vitro anti-tumor activity of N-{1-[(3-thioxo-5,6-dihydroimidazo[2,1-c][1,2,4]thiadiazol-7-ylthio)thiocarbonyl]-2-imidazolidene}arylsulfonamides.,  16  (14): [PMID:16682194] [10.1016/j.bmcl.2006.04.067]

Source